Calsilite Insulation Cement — GAF Corporation (1951–1971)

Calsilite Insulation Cement was an asbestos-containing thermal insulation product manufactured by GAF Corporation and distributed across industrial markets in the United States from approximately 1951 through 1971. Workers who handled, mixed, applied, or disturbed this material during its decades of active use may have sustained occupational asbestos exposure. Individuals diagnosed with asbestos-related diseases after working with or around Calsilite Insulation Cement may be eligible to file a claim with the GAF Corporation Asbestos Settlement Trust.

Product Description

GAF Corporation — the General Aniline and Film Corporation — was a major American chemical and building materials conglomerate with product lines spanning roofing materials, floor tiles, pipe coverings, and specialty industrial cements. Calsilite Insulation Cement was one of several insulating and finishing products the company produced during the postwar industrial expansion period. The product was formulated as a cement-based insulating compound intended for high-temperature industrial applications, including pipe covering, equipment insulation, and related construction and maintenance tasks.

Calsilite was marketed to industrial facilities such as refineries, chemical plants, shipyards, power generation stations, and manufacturing operations where thermal insulation of pipes, boilers, and related equipment was a routine maintenance and construction requirement. The product’s calcium silicate base — combined with asbestos fiber — was promoted for its heat-resistant and binding properties, making it a common choice among insulators and industrial tradespeople throughout the 1950s and 1960s.

GAF Corporation’s involvement in the asbestos products industry has been extensively documented through regulatory filings, litigation records, and the subsequent establishment of the GAF Corporation Asbestos Settlement Trust, which was created to compensate individuals harmed by exposure to the company’s asbestos-containing products, including Calsilite Insulation Cement.

Asbestos Content

Calsilite Insulation Cement contained asbestos fiber as a functional component of its formulation. Asbestos was incorporated into insulation cements of this type because of its well-established properties: thermal resistance, tensile reinforcement, and the ability to bind other materials into a stable, workable matrix. These characteristics made asbestos-containing cements particularly attractive to manufacturers and specifiers working in high-heat industrial environments.

The use of asbestos in insulation cements like Calsilite was consistent with widespread industry practice during the product’s years of production. Regulatory frameworks governing asbestos content in building and industrial materials — including standards later codified under the Asbestos Hazard Emergency Response Act (AHERA) and OSHA’s asbestos exposure regulations — had not yet been established during the bulk of the product’s commercial life. As a result, products such as Calsilite Insulation Cement were produced, sold, and applied without the fiber content disclosures or engineering controls that subsequent regulations would require.

Documentation submitted through the GAF Corporation Asbestos Settlement Trust process identifies Calsilite Insulation Cement as a compensable asbestos-containing product associated with the company’s manufacturing operations.

How Workers Were Exposed

Workers who handled Calsilite Insulation Cement were potentially exposed to airborne asbestos fibers at multiple stages of the product’s use. Insulation cements of this type were typically mixed, troweled, applied, and finished by hand, and each of these tasks had the potential to release respirable asbestos fibers into the surrounding air.

Mixing and preparation presented a significant exposure opportunity. Calsilite was commonly supplied in dry or semi-dry form and required workers to add water and blend the material before application. Dry mixing in particular could generate substantial dust containing asbestos fibers.

Application and finishing required workers to spread, shape, and smooth the cement over pipe surfaces, fittings, and equipment using hand tools. Repeated handling of the wet or partially set material brought workers into direct and prolonged contact with asbestos-containing substances.

Cutting and trimming of set or cured insulation cement — whether for repair, removal, or modification — could release concentrated quantities of asbestos fiber. Grinding, chipping, or sanding hardened cement was among the highest-exposure tasks associated with insulation products of this category.

Bystander exposure was also documented in industrial settings. Pipefitters, boilermakers, electricians, maintenance workers, and other tradespeople working in the same areas as insulation applicators could inhale airborne fibers without directly handling Calsilite themselves.

Exposure to airborne asbestos fibers is associated with serious and potentially fatal diseases, including mesothelioma, asbestosis, lung cancer, and other asbestos-related conditions. These diseases typically have long latency periods — often 20 to 50 years between initial exposure and clinical diagnosis — meaning workers exposed to Calsilite Insulation Cement during the 1950s, 1960s, or early 1970s may be receiving diagnoses today.

The GAF Corporation Asbestos Settlement Trust was established to provide compensation to individuals who sustained asbestos-related injuries as a result of exposure to GAF Corporation’s asbestos-containing products, including Calsilite Insulation Cement. The trust operates under a structured claims process consistent with the practices of asbestos personal injury trusts administered under bankruptcy reorganization proceedings.

Eligible claimants generally include individuals diagnosed with a qualifying asbestos-related disease who can demonstrate occupational or other documented exposure to a GAF Corporation product. Calsilite Insulation Cement is among the products named in trust documentation as a basis for filing eligibility.

Qualifying disease categories typically include:

  • Mesothelioma — malignant cancer of the pleura, peritoneum, or pericardium associated with asbestos exposure
  • Lung cancer — with documented evidence of asbestos exposure as a contributing factor
  • Asbestosis — progressive fibrotic lung disease resulting from sustained asbestos fiber inhalation
  • Other asbestos-related conditions — including pleural plaques, pleural thickening, and diffuse pleural disease, which may be evaluated under the trust’s approved disease categories

Claim documentation requirements for the GAF Corporation Asbestos Settlement Trust generally include medical records confirming diagnosis, work history demonstrating exposure to a covered GAF product such as Calsilite Insulation Cement, and supporting evidence linking the claimant’s occupational history to the product. An experienced asbestos attorney can assist in assembling and submitting the necessary documentation.

Industrial workers who handled Calsilite Insulation Cement during its years of production — as well as surviving family members of deceased workers — are encouraged to consult with a qualified asbestos claims attorney to determine eligibility and initiate the trust claim process. Statutes of limitations apply to asbestos trust claims, and timely filing is essential to preserving legal rights.

This article is provided for informational reference purposes. It documents a specific asbestos-containing product based on available regulatory, litigation, and trust fund records. It does not constitute legal advice. Individuals seeking compensation for asbestos-related illness should consult a licensed attorney.